Great News! IVRS and Succipro Secure Eurostars Funding to Advance Next-Generation Treatment for Crohn’s Disease
We’re proud to share that IVRS AB and Succipro S.L. have received Eurostars funding to develop a new biologic therapy for Crohn’s disease, an important step toward more precise and effective treatments for inflammatory bowel disease (IBD). This collaboration brings together Succipro’s expertise in biologic drug development and IVRS’s advanced in vivo imaging capabilities, creating […]
IVRS welcomes Crown Bioscience to the EUREKA project ONCO-TARGET!
IVRS welcomes Crown Bioscience to the EUREKA project ONCO-TARGET! Two months ago, we welcomed our new collaborator within the EUROSTARS R&D and innovation project is one of the global pioneers when it comes to highlighting the importance of providing research and groundbreaking technologies, and shares the same mission as IVRS; to accelerate and de-risk the process […]
IVRS has initiated a collaboration with RISE!
With the recent expansion of our service array within NIR fluorescent imaging, PDX models and pushing state-of-the-art imaging to its limits, IVRS is ready to offer their services on a wider demographic scale. By teaming up with RISE Research Institutes of Sweden/Drug development at RISE, an independent and state-owned institute with a mission to bridge industry, […]
Positiva prekliniska resultat i Xintelas glioblastomprojekt i samarbete med IVRS
Xintela AB (publ) meddelar positiva prekliniska resultat i glioblastomprojektet. Xintela har utvecklat funktionsblockerande antikroppar som binder till bolagets målmolekyl integrin a10b1 och identifierat en antikropp som hämmar tillväxten av glioblastomtumörer i en preklinisk modell. Arbetet har utförts i samarbete med IVRS (In Vivo Research Services) i Lund. Läs hela pressmeddelandet
Meet us at NLS Days in Malmö in September
We will attend Nordic Life Science Days in Malmö 12-14 of September 2019 at Malmömässan. Meet us there! Read more about NLS Days
